Suchergebnisse - "Zhou, H"

PubPharm (2.912)

1

A Bioreactor Culture of Mesophilic Consortia Maintains the Stability of Microbial Community and Accelerates the Regeneration of Ferric Iron

enthalten in: Microbiology | 2023

von Li, T. | Liu, R. | Zhou, H.

2

Reliability and validity of the Chinese version of adverse childhood experiences international questionnaire in parents of preschool children

enthalten in: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences | 2023

von Mi, X. | Hou, S. | Fu, Z. | +5

3

Experimental Determination of Phase Equilibria in the Ce-Co-Zr Ternary System

enthalten in: Journal of phase equilibria and diffusion | 2023

von Zheng, X. | Liu, X. | Yang, S. | +6

4

3D-printed vertebral body in anterior spinal reconstruction after total spondylectomy for patients with cervical chordoma

enthalten in: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences | 2023

von Zhou, H. | Wang, R. | Liu, Z. | +4

5

A RF plasma source with focused magnetic field for material treatment

enthalten in: Plasma chemistry and plasma processing | 2022

von Zhang, L. | Chang, L. | Yuan, X. | +3

6

Supramolecular Complexes Built of Octahedral [$ Ta_{6} $$ Cl_{12} $(CN)6]3−/4− Clusters and Terpyridine-Metal Complexes

enthalten in: Journal of chemical crystallography | 2022

von Zhang, J. | Zhou, H. | Lachgar, A.

7

Comparison of outcomes of ventral hernia repair using different meshes: a systematic review and network meta-analysis

enthalten in: Hernia | 2022

von Zhou, H. | Shen, Y. | Zhang, Z. | +3

8

Inhibition connexin 43 by mimetic peptide Gap27 mediates protective effects on 6-hydroxydopamine induced Parkinson's disease mouse model

enthalten in: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences | 2022

von Quan, H. | Xu, W. | Qi, Y. | +3

9

Phase Equilibria in Sm-Co-Ti Ternary System

enthalten in: Journal of phase equilibria and diffusion | 2022

von Chen, D. | Luo, L. | Dai, F. | +5

10

Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies

enthalten in: Cancer immunology immunotherapy | 2022

von Moreno, V. | Calvo, E. | Middleton, M. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[292]